A Single Dose, Within Subject, 3 Period, Pharmacokinetic Bridging Study of CoFactor Formulations and of Leucovorin Administered Intravenously in Healthy, Adult Subjects.

Trial Profile

A Single Dose, Within Subject, 3 Period, Pharmacokinetic Bridging Study of CoFactor Formulations and of Leucovorin Administered Intravenously in Healthy, Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2013

At a glance

  • Drugs Folitixorin (Primary) ; Folinic acid
  • Indications Breast cancer; Colorectal cancer; Pancreatic cancer
  • Focus Pharmacokinetics
  • Sponsors Mast Therapeutics
  • Most Recent Events

    • 23 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top